Location History:
- Maharashtra, IN (2010 - 2011)
- Mumbai, IN (2009 - 2012)
Company Filing History:
6 out of 21 
1 out of 48 
1 out of 5 Years Active: 2009-2012
Title: Asha Adrian Kulkarni-Almeida: Innovator in Pharmaceutical Sciences
Introduction
Asha Adrian Kulkarni-Almeida is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for medical applications. With a total of eight patents to her name, her work focuses on innovative solutions for treating various clinical conditions.
Latest Patents
Among her latest patents is a groundbreaking invention related to pyridyl derivatives. These derivatives are capable of inhibiting phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR), and hypoxia-inducible factor 1α (HIF-1α) mediated signaling. The invention also includes processes for the preparation of these derivatives and their use in pharmaceutical compositions aimed at treating conditions caused by the deregulation of these signaling pathways. Additionally, she has developed anti-inflammatory compounds obtained through the fermentation of Myxobacteria strain (PM0670013/MTCC 5570). This invention encompasses processes for producing these novel compounds and their application in medicines for treating inflammatory diseases mediated by pro-inflammatory cytokines.
Career Highlights
Asha has worked with notable companies such as Piramal Life Sciences Limited and Piramal Enterprises Limited. Her experience in these organizations has allowed her to contribute significantly to research and development in the pharmaceutical sector.
Collaborations
Throughout her career, Asha has collaborated with esteemed colleagues, including Ravindra Dattatraya Gupte and Sapna Parikh. These collaborations have further enhanced her research capabilities and innovation potential.
Conclusion
Asha Adrian Kulkarni-Almeida stands out as a leading inventor in the pharmaceutical industry, with her innovative patents addressing critical health issues. Her contributions continue to pave the way for advancements in medical treatments and therapies.